Daniel Van Plew P.'s most recent trade in Regeneron Pharmaceuticals, Inc. was a trade of 969 Common Stock done at an average price of $730.8 . Disclosure was reported to the exchange on Dec. 16, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Regeneron Pharma | P. Van Plew Daniel | EVP & General Mgr, Industrial | Payment of exercise price or tax liability using portion of securities received from the company at price $ 730.81 per share. | 16 Dec 2024 | 969 | 34,792 (0%) | 0% | 730.8 | 708,155 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Dec 2024 | 13,472 | 13,472 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Dec 2024 | 3,499 | 36,253 (0%) | 0% | 0 | Common Stock | |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Payment of exercise price or tax liability using portion of securities received from the company at price $ 787.00 per share. | 06 Dec 2024 | 492 | 35,761 (0%) | 0% | 787 | 387,204 | Common Stock |
| Regeneron Pharma | P. Daniel Van Plew | EVP & General Mgr, Industrial | Sale of securities on an exchange or to another person at price $ 940.44 per share. | 14 Feb 2024 | 4,261 | 25,136 (0%) | 0% | 940.4 | 4,007,215 | Common Stock |
| Regeneron Pharma | Van Plew P. Daniel | EVP & General Mgr, Industrial | Sale of securities on an exchange or to another person at price $ 943.51 per share. | 14 Feb 2024 | 2,691 | 22,170 (0%) | 0% | 943.5 | 2,538,985 | Common Stock |
| Regeneron Pharma | P. Daniel Van Plew | EVP & General Mgr, Industrial | Sale of securities on an exchange or to another person at price $ 939.60 per share. | 14 Feb 2024 | 750 | 29,397 (0%) | 0% | 939.6 | 704,700 | Common Stock |
| Regeneron Pharma | Daniel Van Plew P. | EVP & General Mgr, Industrial | Sale of securities on an exchange or to another person at price $ 944.30 per share. | 14 Feb 2024 | 620 | 21,550 (0%) | 0% | 944.3 | 585,466 | Common Stock |
| Regeneron Pharma | P. Daniel Van Plew | EVP & General Mgr, Industrial | Sale of securities on an exchange or to another person at price $ 937.94 per share. | 14 Feb 2024 | 439 | 30,373 (0%) | 0% | 937.9 | 411,756 | Common Stock |
| Regeneron Pharma | P. Daniel Van Plew | EVP & General Mgr, Industrial | Sale of securities on an exchange or to another person at price $ 950.45 per share. | 14 Feb 2024 | 375 | 20,578 (0%) | 0% | 950.5 | 356,419 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Sale of securities on an exchange or to another person at price $ 941.41 per share. | 14 Feb 2024 | 275 | 24,861 (0%) | 0% | 941.4 | 258,888 | Common Stock |
| Regeneron Pharma | Van Plew P. Daniel | EVP & General Mgr, Industrial | Sale of securities on an exchange or to another person at price $ 947.81 per share. | 14 Feb 2024 | 240 | 21,215 (0%) | 0% | 947.8 | 227,474 | Common Stock |
| Regeneron Pharma | Daniel Van Plew P. | EVP & General Mgr, Industrial | Sale of securities on an exchange or to another person at price $ 938.13 per share. | 14 Feb 2024 | 226 | 30,147 (0%) | 0% | 938.1 | 212,017 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Sale of securities on an exchange or to another person at price $ 951.77 per share. | 14 Feb 2024 | 200 | 20,378 (0%) | 0% | 951.8 | 190,354 | Common Stock |
| Regeneron Pharma | Van Plew Daniel P. | EVP & General Mgr, Industrial | Sale of securities on an exchange or to another person at price $ 948.70 per share. | 14 Feb 2024 | 150 | 21,065 (0%) | 0% | 948.7 | 142,305 | Common Stock |
| Regeneron Pharma | P. Van Plew Daniel | EVP & General Mgr, Industrial | Sale of securities on an exchange or to another person at price $ 949.07 per share. | 14 Feb 2024 | 112 | 20,953 (0%) | 0% | 949.1 | 106,296 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Sale of securities on an exchange or to another person at price $ 945.81 per share. | 14 Feb 2024 | 95 | 21,455 (0%) | 0% | 945.8 | 89,852 | Common Stock |
| Regeneron Pharma | P. Daniel Van Plew | EVP & General Mgr, Industrial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 381.40 per share. | 09 Feb 2024 | 23,125 | 47,153 (0%) | 0% | 381.4 | 8,819,875 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 23,125 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Payment of exercise price or tax liability using portion of securities received from the company at price $ 951.68 per share. | 09 Feb 2024 | 16,341 | 30,812 (0%) | 0% | 951.7 | 15,551,403 | Common Stock |
| Regeneron Pharma | Van Plew Daniel P. | EVP & General Mgr, Industrial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 372.46 per share. | 09 Feb 2024 | 12,250 | 32,628 (0%) | 0% | 372.5 | 4,562,635 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 12,250 | 12,250 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Payment of exercise price or tax liability using portion of securities received from the company at price $ 951.68 per share. | 09 Feb 2024 | 8,600 | 24,028 (0%) | 0% | 951.7 | 8,184,448 | Common Stock |
| Regeneron Pharma | Van Plew Daniel P. | EVP & General Mgr, Industrial | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2023 | 11,473 | 11,473 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | P. Van Plew Daniel | EVP & General Mgr, Industrial | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2023 | 3,199 | 23,599 (0%) | 0% | 0 | Common Stock | |
| Regeneron Pharma | Daniel Van Plew P. | EVP & General Mgr, Industrial | Payment of exercise price or tax liability using portion of securities received from the company at price $ 844.09 per share. | 08 Dec 2023 | 2,552 | 21,047 (0%) | 0% | 844.1 | 2,154,118 | Common Stock |
| Regeneron Pharma | P. Daniel Van Plew | EVP & General Mgr, Industrial | Payment of exercise price or tax liability using portion of securities received from the company at price $ 843.79 per share. | 08 Dec 2023 | 1,108 | 20,400 (0%) | 0% | 843.8 | 934,919 | Common Stock |
| Regeneron Pharma | Van Plew Daniel P. | EVP & General Mgr, Industrial | Payment of exercise price or tax liability using portion of securities received from the company at price $ 844.09 per share. | 08 Dec 2023 | 669 | 20,378 (0%) | 0% | 844.1 | 564,696 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Aug 2023 | 23,125 | 23,125 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 381.40 per share. | 23 Aug 2023 | 23,125 | 44,633 (0%) | 0% | 381.4 | 8,819,875 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Payment of exercise price or tax liability using portion of securities received from the company at price $ 842.66 per share. | 23 Aug 2023 | 16,928 | 27,705 (0%) | 0% | 842.7 | 14,264,548 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Sale of securities on an exchange or to another person at price $ 844.27 per share. | 23 Aug 2023 | 2,534 | 21,508 (0%) | 0% | 844.3 | 2,139,380 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Sale of securities on an exchange or to another person at price $ 843.31 per share. | 23 Aug 2023 | 759 | 24,042 (0%) | 0% | 843.3 | 640,072 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Sale of securities on an exchange or to another person at price $ 838.37 per share. | 23 Aug 2023 | 667 | 25,975 (0%) | 0% | 838.4 | 559,193 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Sale of securities on an exchange or to another person at price $ 836.32 per share. | 23 Aug 2023 | 625 | 26,942 (0%) | 0% | 836.3 | 522,700 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Sale of securities on an exchange or to another person at price $ 842.66 per share. | 23 Aug 2023 | 617 | 24,801 (0%) | 0% | 842.7 | 519,921 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Sale of securities on an exchange or to another person at price $ 841.15 per share. | 23 Aug 2023 | 363 | 25,418 (0%) | 0% | 841.1 | 305,337 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Sale of securities on an exchange or to another person at price $ 837.53 per share. | 23 Aug 2023 | 300 | 26,642 (0%) | 0% | 837.5 | 251,259 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Sale of securities on an exchange or to another person at price $ 839.28 per share. | 23 Aug 2023 | 148 | 25,827 (0%) | 0% | 839.3 | 124,213 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Sale of securities on an exchange or to another person at price $ 835.67 per share. | 23 Aug 2023 | 138 | 27,567 (0%) | 0% | 835.7 | 115,322 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Sale of securities on an exchange or to another person at price $ 840.74 per share. | 23 Aug 2023 | 46 | 25,781 (0%) | 0% | 840.7 | 38,674 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2022 | 14,019 | 14,019 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2022 | 3,798 | 33,884 (0%) | 0% | 0 | Common Stock | |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Payment of exercise price or tax liability using portion of securities received from the company at price $ 753.28 per share. | 09 Dec 2022 | 492 | 30,086 (0%) | 0% | 753.3 | 370,614 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 378.98 per share. | 22 Nov 2022 | 50,000 | 80,578 (0%) | 0% | 379.0 | 18,949,000 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Nov 2022 | 50,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Payment of exercise price or tax liability using portion of securities received from the company at price $ 741.81 per share. | 22 Nov 2022 | 38,028 | 42,550 (0%) | 0% | 741.8 | 28,209,551 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Sale of securities on an exchange or to another person at price $ 739.48 per share. | 22 Nov 2022 | 3,124 | 36,418 (0%) | 0% | 739.5 | 2,310,136 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Sale of securities on an exchange or to another person at price $ 740.29 per share. | 22 Nov 2022 | 1,808 | 34,610 (0%) | 0% | 740.3 | 1,338,444 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Sale of securities on an exchange or to another person at price $ 746.42 per share. | 22 Nov 2022 | 1,164 | 31,208 (0%) | 0% | 746.4 | 868,833 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Sale of securities on an exchange or to another person at price $ 736.46 per share. | 22 Nov 2022 | 1,005 | 40,859 (0%) | 0% | 736.5 | 740,142 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Sale of securities on an exchange or to another person at price $ 741.34 per share. | 22 Nov 2022 | 1,002 | 33,608 (0%) | 0% | 741.3 | 742,823 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Sale of securities on an exchange or to another person at price $ 738.57 per share. | 22 Nov 2022 | 944 | 39,542 (0%) | 0% | 738.6 | 697,210 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Sale of securities on an exchange or to another person at price $ 744.56 per share. | 22 Nov 2022 | 780 | 32,628 (0%) | 0% | 744.6 | 580,757 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Sale of securities on an exchange or to another person at price $ 735.57 per share. | 22 Nov 2022 | 686 | 41,864 (0%) | 0% | 735.6 | 504,601 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Sale of securities on an exchange or to another person at price $ 747.28 per share. | 22 Nov 2022 | 629 | 30,579 (0%) | 0% | 747.3 | 470,039 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Sale of securities on an exchange or to another person at price $ 737.37 per share. | 22 Nov 2022 | 373 | 40,486 (0%) | 0% | 737.4 | 275,039 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Sale of securities on an exchange or to another person at price $ 745.56 per share. | 22 Nov 2022 | 256 | 32,372 (0%) | 0% | 745.6 | 190,863 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Sale of securities on an exchange or to another person at price $ 743.66 per share. | 22 Nov 2022 | 101 | 33,408 (0%) | 0% | 743.7 | 75,110 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Sale of securities on an exchange or to another person at price $ 742.58 per share. | 22 Nov 2022 | 99 | 33,509 (0%) | 0% | 742.6 | 73,515 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Sale of securities on an exchange or to another person at price $ 748.00 per share. | 22 Nov 2022 | 1 | 30,578 (0%) | 0% | 748 | 748 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Nov 2022 | 34,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 381.92 per share. | 04 Nov 2022 | 34,000 | 64,578 (0%) | 0% | 381.9 | 12,985,280 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Payment of exercise price or tax liability using portion of securities received from the company at price $ 725.84 per share. | 04 Nov 2022 | 26,114 | 38,464 (0%) | 0% | 725.8 | 18,954,586 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Sale of securities on an exchange or to another person at price $ 746.56 per share. | 04 Nov 2022 | 2,782 | 30,982 (0%) | 0% | 746.6 | 2,076,930 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Sale of securities on an exchange or to another person at price $ 744.61 per share. | 04 Nov 2022 | 2,032 | 35,232 (0%) | 0% | 744.6 | 1,513,048 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Sale of securities on an exchange or to another person at price $ 745.51 per share. | 04 Nov 2022 | 1,468 | 33,764 (0%) | 0% | 745.5 | 1,094,409 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Sale of securities on an exchange or to another person at price $ 743.39 per share. | 04 Nov 2022 | 1,100 | 37,264 (0%) | 0% | 743.4 | 817,729 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Sale of securities on an exchange or to another person at price $ 747.20 per share. | 04 Nov 2022 | 404 | 30,578 (0%) | 0% | 747.2 | 301,869 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Sale of securities on an exchange or to another person at price $ 742.79 per share. | 04 Nov 2022 | 100 | 38,364 (0%) | 0% | 742.8 | 74,279 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2022 | 40,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 555.67 per share. | 09 Sep 2022 | 40,000 | 70,578 (0%) | 0% | 555.7 | 22,226,800 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Payment of exercise price or tax liability using portion of securities received from the company at price $ 730.96 per share. | 09 Sep 2022 | 35,304 | 35,274 (0%) | 0% | 731.0 | 25,805,812 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Sale of securities on an exchange or to another person at price $ 716.28 per share. | 09 Sep 2022 | 1,052 | 32,253 (0%) | 0% | 716.3 | 753,527 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Sale of securities on an exchange or to another person at price $ 715.39 per share. | 09 Sep 2022 | 861 | 33,305 (0%) | 0% | 715.4 | 615,951 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Sale of securities on an exchange or to another person at price $ 717.59 per share. | 09 Sep 2022 | 647 | 31,606 (0%) | 0% | 717.6 | 464,281 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Sale of securities on an exchange or to another person at price $ 713.67 per share. | 09 Sep 2022 | 572 | 34,433 (0%) | 0% | 713.7 | 408,219 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Sale of securities on an exchange or to another person at price $ 718.50 per share. | 09 Sep 2022 | 435 | 31,171 (0%) | 0% | 718.5 | 312,548 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Sale of securities on an exchange or to another person at price $ 714.42 per share. | 09 Sep 2022 | 267 | 34,166 (0%) | 0% | 714.4 | 190,750 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Sale of securities on an exchange or to another person at price $ 720.41 per share. | 09 Sep 2022 | 181 | 30,831 (0%) | 0% | 720.4 | 130,394 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Sale of securities on an exchange or to another person at price $ 721.38 per share. | 09 Sep 2022 | 174 | 30,657 (0%) | 0% | 721.4 | 125,520 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Sale of securities on an exchange or to another person at price $ 719.72 per share. | 09 Sep 2022 | 159 | 31,012 (0%) | 0% | 719.7 | 114,435 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Sale of securities on an exchange or to another person at price $ 712.44 per share. | 09 Sep 2022 | 110 | 35,005 (0%) | 0% | 712.4 | 78,368 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Sale of securities on an exchange or to another person at price $ 709.93 per share. | 09 Sep 2022 | 87 | 35,187 (0%) | 0% | 709.9 | 61,764 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Sale of securities on an exchange or to another person at price $ 722.84 per share. | 09 Sep 2022 | 79 | 30,578 (0%) | 0% | 722.8 | 57,104 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Sale of securities on an exchange or to another person at price $ 711.86 per share. | 09 Sep 2022 | 70 | 35,115 (0%) | 0% | 711.9 | 49,830 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Sale of securities on an exchange or to another person at price $ 710.50 per share. | 09 Sep 2022 | 2 | 35,185 (0%) | 0% | 710.5 | 1,421 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 399.66 per share. | 22 Feb 2022 | 40,000 | 70,578 (0%) | 0% | 399.7 | 15,986,400 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2022 | 40,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Payment of exercise price or tax liability using portion of securities received from the company at price $ 610.56 per share. | 22 Feb 2022 | 33,219 | 37,359 (0%) | 0% | 610.6 | 20,282,193 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Sale of securities on an exchange or to another person at price $ 617.48 per share. | 22 Feb 2022 | 1,176 | 31,593 (0%) | 0% | 617.5 | 726,156 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Sale of securities on an exchange or to another person at price $ 618.16 per share. | 22 Feb 2022 | 1,015 | 30,578 (0%) | 0% | 618.2 | 627,432 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Sale of securities on an exchange or to another person at price $ 611.65 per share. | 22 Feb 2022 | 800 | 35,003 (0%) | 0% | 611.7 | 489,320 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Sale of securities on an exchange or to another person at price $ 608.29 per share. | 22 Feb 2022 | 800 | 36,403 (0%) | 0% | 608.3 | 486,632 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Sale of securities on an exchange or to another person at price $ 616.40 per share. | 22 Feb 2022 | 734 | 32,769 (0%) | 0% | 616.4 | 452,438 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Sale of securities on an exchange or to another person at price $ 614.53 per share. | 22 Feb 2022 | 600 | 33,803 (0%) | 0% | 614.5 | 368,718 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Sale of securities on an exchange or to another person at price $ 612.44 per share. | 22 Feb 2022 | 600 | 34,403 (0%) | 0% | 612.4 | 367,464 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Sale of securities on an exchange or to another person at price $ 609.62 per share. | 22 Feb 2022 | 400 | 36,003 (0%) | 0% | 609.6 | 243,848 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Sale of securities on an exchange or to another person at price $ 615.20 per share. | 22 Feb 2022 | 300 | 33,503 (0%) | 0% | 615.2 | 184,560 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Sale of securities on an exchange or to another person at price $ 610.41 per share. | 22 Feb 2022 | 200 | 35,803 (0%) | 0% | 610.4 | 122,082 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Sale of securities on an exchange or to another person at price $ 607.94 per share. | 22 Feb 2022 | 156 | 37,203 (0%) | 0% | 607.9 | 94,839 | Common Stock |